Ology Bioservices, Inc. Will Receive $9 Million of Funding to Support Manufacturing of Nipah Virus Vaccine
The Coalition for Epidemic Preparedness Innovations (CEPI) will provide $43.6 million to advance the development and manufacture of the rVSV-Nipah vaccine candidate... Read More
Blue Water Vaccines, Developing Universal Flu Vaccine, to Partner With Ology Bioservices Inc.
Blue Water Vaccines, a Cincinnati-based biotechnology startup, has signed an agreement with UF startup Ology Bioservices, Inc., a biologics contract development and... Read More
Morphogenesis, Inc. Is Testing Cancer Vaccine
Scientists at UF startup Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, call the “therapeutic vaccine” a simple and safe technology... Read More
Virtual Humans Boost Mental Health Recovery
Benjamin Lok, a professor in the computer and information science and engineering department at the University of Florida, has been studying applications... Read More
Morphogenesis, Inc. Is Developing a Cell and Gene Therapy Focusing on a Cancer Vaccine Immunotherapy That Uses the Body’s Own Immune System to Kill Solid Tumors
Dr. Patricia Lawman, CEO and co-founder of UF startup Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, talks about the company,... Read More
Startup CEO Discusses Business Growth After Receiving Funding
UF startup Peerfit founder and CEO Ed Buckley gained a lot of traction with his business after receiving investment funding and coaching... Read More
Algernon Pharmaceuticals Announces Russian Athletic Performance Enhancing Drugs Bemethyl (NP-135) and Bromantane (NP-160) Exhibited Potent Anti-Fibrotic Activity in NASH and CKD Studies
Algernon Pharmaceuticals Inc., formerly known as Breathtec, a UF startup, is pleased to report that its lead drugs for non-alcoholic steatohepatitis (NASH)... Read More
Pheromones Give Nematodes a Boost in Controlling Pests
UF Innovate alumni startup Pheronym, an ag-biotech pest control company that develops and produces nematode pheromones that can be used to direct... Read More
US Biotech Startup Eyes 2020 Avian Necrotic Enteritis Vaccine Launch
Founded in 2015, UF startup Curtiss Healthcare commercialized UF researcher Dr. Roy Curtiss III’s research into orally distributed Salmonella vector vaccines. The... Read More
AGTC Completes Enrollment of Third Group in the Dose Escalation Portion of the Achromatopsia CNGA3 Phase 1/2 Clinical Study
UF startup and UF Innovate│Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated... Read More
